See how top analysts and institutions rate CRWV — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Evercore ISI | Initiated | Outperform | $175 | 2025-09-30 |
| Melius | Upgrade | Hold → Buy | $165 | 2025-09-23 |
| Wells Fargo | Upgrade | Equal Weight → Overweight | $170 | 2025-09-23 |
| Loop Capital | Initiated | Buy | $165 | 2025-09-19 |
| Citizens JMP | Upgrade | Mkt Perform → Mkt Outperform | $180 | 2025-09-16 |
| Raymond James | Initiated | Outperform | $130 | 2025-09-16 |
| Cantor Fitzgerald | Initiated | Overweight | $116 | 2025-08-27 |
| H.C. Wainwright | Upgrade | Neutral → Buy | $180 | 2025-08-21 |
| Arete | Upgrade | Neutral → Buy | $180 | 2025-08-21 |
| Citigroup | Upgrade | Neutral → Buy | $160 | 2025-07-31 |
| HSBC Securities | Initiated | Reduce | $32 | 2025-07-17 |
| Argus | Initiated | Buy | $200 | 2025-07-11 |
| Needham | Downgrade | Buy → Hold | 2025-07-10 | |
| Mizuho | Downgrade | Outperform → Neutral | $150 | 2025-07-08 |
| Stifel | Downgrade | Buy → Hold | $115 | 2025-07-08 |
| H.C. Wainwright | Initiated | Neutral | 2025-06-25 | |
| BofA Securities | Downgrade | Buy → Neutral | $185 | 2025-06-16 |
| Arete | Initiated | Neutral | $130 | 2025-06-05 |
| Barclays | Downgrade | Overweight → Equal Weight | $100 | 2025-05-27 |
| Citizens JMP | Initiated | Mkt Perform | 2025-05-22 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 4 | 10 | 9 | 2 | 1 |
| October 2025 | 4 | 10 | 9 | 2 | 1 |
| September 2025 | 4 | 9 | 11 | 2 | 1 |
| August 2025 | 2 | 5 | 13 | 2 | 1 |
The majority of institutional investors have issued a "Buy" rating for CRWV, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
